Berachain’s new proof-of-liquidity blockchain is almost live. Here’s what you need to know about the network and its BERA ...

Of the 10 largest US active ETFs, January’s top performer was the $13.4 billion Capital Group Dividend Value ETF, which gained 4.29%. The bottom performer was the $28.8 billion JPMorgan Ultra-Short ...

As the cryptocurrency deals with record ups and downs, its community has approved a hotly debated technical change to gas ...

The announcement of DeepSeek R1 triggered a major downturn in U.S. tech stocks, with Nvidia (-15.81%), Broadcom (-9.57%) and Oracle (-7.37%) suffering sharp declines. Investors fear that DeepSeek’s ...

Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 3050 in its ...

The Vanguard Short-Term Bond ETF (BSV) holds a diverse range of government, investment-grade corporate, and investment-grade ...

Budget uncertainty led to a muted start to the 2024-25 venture capital trust (VCT) fundraising season. However, with VCTs emerging unscathed by the chancellor's plans and the tax year end drawing ...

Mankind Pharma's shares dropped almost 6 per cent on 24 January, impacted by a decline in the company's net profit for ...

Mankind Pharma Ltd.'s share price declined more than 5% during early trade on Friday after the company's third-quarter ...

Mankind Pharma on Thursday said its consolidated net profit declined 16.5 per cent to Rs 384 crore in the third quarter ended December 31, 2024. The company had reported a net profit of Rs 460 crore ...